U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C40H62O14
Molecular Weight 766.9119
Optical Activity UNSPECIFIED
Defined Stereocenters 20 / 20
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of WITHANOSIDE V

SMILES

[H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](C[C@H](O)[C@]4(C)[C@@]3([H])CC[C@]12C)O[C@]5([H])O[C@H](CO[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@H](O)[C@H](O)[C@H]5O)[C@H](C)[C@@]7([H])CC(C)=C(C)C(=O)O7

InChI

InChIKey=ZBLWKSUMHLVXAM-KFJRISAASA-N
InChI=1S/C40H62O14/c1-17-12-26(52-36(49)18(17)2)19(3)23-8-9-24-22-7-6-20-13-21(14-29(42)40(20,5)25(22)10-11-39(23,24)4)51-38-35(48)33(46)31(44)28(54-38)16-50-37-34(47)32(45)30(43)27(15-41)53-37/h6,19,21-35,37-38,41-48H,7-16H2,1-5H3/t19-,21+,22-,23+,24-,25-,26+,27+,28+,29-,30+,31+,32-,33-,34+,35+,37+,38+,39+,40-/m0/s1

HIDE SMILES / InChI

Description
Curator's Comment: Description was created based on several sources, including http://www.realnatural.org/over-fifty-recent-studies-prove-ashwagandhas-potential-for-treating-a-myriad-of-conditions/

Withanoside V is a glycowithanolide of W.somnifera. Ashwagandha (Withania somnifera) contains a myriad of constituents, including withanolides named withanolide A, withanolide B, withaferin A, and withanone, along with 12-deoxy withastramonolide, withanoside V, withanoside IV. Withanoside V has shown high antioxidant potential.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum.
2001 Jun
Optimization of elicitation conditions with methyl jasmonate and salicylic acid to improve the productivity of withanolides in the adventitious root culture of Withania somnifera (L.) Dunal.
2012 Oct
Characterization of Withania somnifera leaf transcriptome and expression analysis of pathogenesis-related genes during salicylic acid signaling.
2014
Patents

Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Name Type Language
WITHANOSIDE V
Common Name English
ERGOSTA-5,24-DIEN-26-OIC ACID, 3-((6-O-.BETA.-D-GLUCOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)-1,22-DIHYDROXY-,.SIGMA.-LACTONE, (1.ALPHA.,3.BETA.,22R)-
Systematic Name English
WITHANOSIDE V (CONSTITUENT OF ASHWAGANDHA ROOT) [DSC]
Common Name English
Code System Code Type Description
FDA UNII
EKV8XP7MQ6
Created by admin on Sat Dec 16 03:15:16 GMT 2023 , Edited by admin on Sat Dec 16 03:15:16 GMT 2023
PRIMARY
EPA CompTox
DTXSID20443612
Created by admin on Sat Dec 16 03:15:16 GMT 2023 , Edited by admin on Sat Dec 16 03:15:16 GMT 2023
PRIMARY
PUBCHEM
10700345
Created by admin on Sat Dec 16 03:15:16 GMT 2023 , Edited by admin on Sat Dec 16 03:15:16 GMT 2023
PRIMARY
CAS
256520-90-8
Created by admin on Sat Dec 16 03:15:16 GMT 2023 , Edited by admin on Sat Dec 16 03:15:16 GMT 2023
PRIMARY